316 related articles for article (PubMed ID: 4247613)
1. The long-acting thyroid stimulator and thyroid disease.
Kriss JP
Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
[No Abstract] [Full Text] [Related]
2. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
Strumia E
Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
[No Abstract] [Full Text] [Related]
3. The nature and significance of the long-acting thyroid stimulator.
Kriss J
Adv Metab Disord; 1968; 3():209-30. PubMed ID: 4178338
[No Abstract] [Full Text] [Related]
4. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
5. Thyroid eye disease and its relationship to the long-acting thyroid stimulator.
Hollows FC; Beaumont P
Trans Aust Coll Ophthalmol; 1969; 1():37-44. PubMed ID: 4250318
[No Abstract] [Full Text] [Related]
6. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
7. The long-acting thyroid stimulator.
Munro DS
Curr Top Exp Endocrinol; 1971; 1():175-98. PubMed ID: 4350824
[No Abstract] [Full Text] [Related]
8. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
9. Neonatal thyrotoxicosis with long acting thyroid stimulator-protector.
O'Hearlihy C
Ir Med J; 1977 Mar; 70(4):124-5. PubMed ID: 576864
[No Abstract] [Full Text] [Related]
10. Pathogenesis of neonatal Graves' disease.
McKenzie JM; Zakarija M
J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
[No Abstract] [Full Text] [Related]
11. Endocrine exophthalmos: an immunologic aberration.
Kaplan HJ
Ophthalmic Semin; 1977; 2(2):203-46. PubMed ID: 327376
[No Abstract] [Full Text] [Related]
12. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
13. [Long-acting thyroid stimulator (L.A.T.S.) and its place in the physiopathogeny of Basedowian hyperthyroidism].
Guéritée N
Rev Fr Endocrinol Clin; 1968; 9(4):351-66. PubMed ID: 5755332
[No Abstract] [Full Text] [Related]
14. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
15. Editorial: Auto-immunity in thyroid disease.
Chhetri MK; Neelakantan C
J Indian Med Assoc; 1973 Nov; 61(10):439-40. PubMed ID: 4801912
[No Abstract] [Full Text] [Related]
16. [Etiology of hyperthyroidism].
Lemarchand-Béraud T; Vannotti A; Griessen M
Schweiz Med Wochenschr; 1967 Oct; 97(41):1342-52. PubMed ID: 5631864
[No Abstract] [Full Text] [Related]
17. [Neonatal Basedow's disease].
Gilbert-Dreyfus ; Peillon F; Amiel C; Delzant G; Sebaoun J; Savoie JC; Minkowski A
Rev Fr Etud Clin Biol; 1967 Dec; 12(10):958-71. PubMed ID: 5632312
[No Abstract] [Full Text] [Related]
18. Pretibial myxedema and nonthyrotoxic thyroid disease.
Lynch PJ; Maize JC; Sisson JC
Arch Dermatol; 1973 Jan; 107(1):107-11. PubMed ID: 4118738
[No Abstract] [Full Text] [Related]
19. The long-acting thyroid stimulator.
Munro DS
J R Coll Physicians Lond; 1972 Apr; 6(3):309-15. PubMed ID: 5066947
[No Abstract] [Full Text] [Related]
20. [Etiology of Basedow's disease, with special reference to LATS].
Nagata K
Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
